1 Min Read
Nov 9 (Reuters) - RECIPHARM AB (PUBL):
* Q3 EBITDA SEK 103 MILLION VERSUS SEK 144 MILLION YEAR AGO
* Q3 NET SALES SEK 1.20 BILLION VERSUS SEK 1.14 BILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.